GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dis-Chem Pharmacies Ltd (JSE:DCP) » Definitions » YoY EBITDA Growth

Dis-Chem Pharmacies (JSE:DCP) YoY EBITDA Growth : -9.82% (As of Aug. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Dis-Chem Pharmacies YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Dis-Chem Pharmacies's YoY EBITDA Growth for the quarter that ended in Aug. 2023 was -9.82%.

Dis-Chem Pharmacies's EBITDA per Share for the six months ended in Aug. 2023 was R1.07.


Dis-Chem Pharmacies YoY EBITDA Growth Historical Data

The historical data trend for Dis-Chem Pharmacies's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dis-Chem Pharmacies YoY EBITDA Growth Chart

Dis-Chem Pharmacies Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.19 -2.10 7.77 20.86 15.87

Dis-Chem Pharmacies Semi-Annual Data
Feb14 Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.47 18.19 32.85 -2.18 -9.82

Dis-Chem Pharmacies YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Dis-Chem Pharmacies's YoY EBITDA Growth for the fiscal year that ended in Feb. 2023 is calculated as:

YoY EBITDA Growth (A: Feb. 2023 )
=(EBITDA per Share (A: Feb. 2023 )-EBITDA per Share (A: Feb. 2022 ))/ | EBITDA per Share (A: Feb. 2022 ) |
=(3.242-2.798)/ | 2.798 |
=15.87 %

Dis-Chem Pharmacies's YoY EBITDA Growth for the quarter that ended in Aug. 2023 is calculated as:

YoY EBITDA Growth (Q: Aug. 2023 )
=(EBITDA per Share (Q: Aug. 2023 )-EBITDA per Share (Q: Aug. 2022 )) / | EBITDA per Share (Q: Aug. 2022 )) |
=(1.065-1.181)/ | 1.181 |
=-9.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dis-Chem Pharmacies YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Dis-Chem Pharmacies's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Dis-Chem Pharmacies (JSE:DCP) Business Description

Traded in Other Exchanges
N/A
Address
23 Stag Road, Glen Austin, Midrand, Johannesburg, GT, ZAF, 1685
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceutical and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries its business operations principally in South Africa.